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ABSTRACT
ancer has assumed and maintained a state of 
public health importance. Unravelling the Caetiopathogenesis of common cancers is key to 
effective control. Microbial infections have become 
increasingly important in the formation of cancers, and 
are of greater importance in tropical parts of the world. 
Most of the emphasis has been on viruses and bacteria, 
and although largely overlooked, protozoa are an 
increasingly important factor in microbial 
carcinogenesis.
The International Agency for Research on Cancer 
[IARC], in 1990, stated that Schistosoma haematobium 
infection was associated with a five-fold increase in the 
risk of squamous cell carcinoma of the bladder, while in 
1994, direct links were documented between Liver 
Flukes [Opistorchis sp and Clonorchis sp] and 
cholangiocarcinoma of both intra and extra hepatic bile 
[1]
ducts.
Notably Plasmodium falciparum infection has been 
labelled as a co-factor in the pathogenesis of endemic 
[2]
Burkitt lymphoma.  Although several studies suggest 
an association between malaria and BL, there has never 
been a conclusive population study in support of a 
[2]
direct role of malaria in causation of BL.  Over the last 
few decades there has been an increased intensity in the 
search for scientifically viable links between parasites 
and cancers, especially in the background of “double 
burden of disease” in tropical regions as well as 
improved survival of immunosuppressed individuals.
Cancers arise from abnormal unregulated growth of 
cells leading to abnormal form or function of body 
organs. It has attained a status of global public health 
importance, accounting for more deaths than HIV and 
[3]
Tuberculosis combined.  Cancer has defied previously 
imposed labels of “disease of rich nations” accounting 
for an increasing number of deaths in Africa and other 
3rd world regions. The cancer burden in developing 
[3]
countries is approaching pandemic proportions.   
More than half of the 12.4 million new cases of cancer in 
2008, and two-thirds of the estimated 7.6 million deaths 
[3]
occur in low and middle income countries.  Once 
shrouded in mystery, there has been an explosion of 
knowledge with regards the inception and progression 
of cancers.  Consequently, the role of infection has been 
radically redefined in the last few years, attaining a 
state of increasing relevance. The American Cancer 
Society recently stated that infections are linked to 15-
20% of cancers, while El-Gayar observed that cancer 
cases in developing countries can be lowered by more 
[4,5]
than 25%, if infections are properly treated.   It is 
equally estimated that cancers attributable to infections 
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overlooked protozoa and recently elucidated 
molecular pathways in both protozoan and metazoan 
carcinogenesis, we conducted a database search (on 
Pub Med and Google Scholar) using broad terms 
related to the intended review such as Parasites and 
Cancer, Carcinogenic Protozoa, Molecular basis of 
Parasitic Carcinogenesis. Etc. references in the 
identified articles were also screened. A total of 79 
articles published in English were found, of which 11 
were unobtainable. Articles found were screened for 
content and relevance. Of the 68 articles identified, 65 
were found relevant and referenced.  
PROTOZOA  AND THEIR NOVEL PATHWAYS OF 
TUMORIGENESIS
Cryptosporidium parvum
This unicellular protozoan is a genus of Apicomplexa 
and class Sporozoa that causes infections of the 
[12]
gastrointestinal and respiratory tracts.  It's a frequent 
cause of diarrhea in both immunocompetent and 
immune deficient individuals. Its presence however, 
carries a higher risk of colorectal malignancy in severe 
[13]
immunosuppression. A study in Poland showed that 
Cryptosporidium parvum was seen  in 18% of cases of 
colorectal cancer, while a study by El-gayar observed 
that in mice having cryptosporidiosis, adenomas and 
invasive neoplasia were detected in the stomach 
[5,14]
duodenum and ileocecal region.  A study in Egypt 
observed dysplastic changes in 80% of colonic biopsies 
of rats infected with Cryptosporidium parvum , while 
Certad documented an increase in mitosis, alongside 
low and high grade intra epithelial neoplasia in 
[14,15]
different areas of the digestive tract.
Increased mitosis was demonstrated on a molecular 
level in studies by Certad, which show enhanced 
staining with  Ki-67, [a marker of mitosis] while an 
increased expression of the cell cycle protein, Cyclin D1 
[14,15]
was observed in an animal study by Abdou et al.  
Several other studies have documented alterations in 
the expression  of inhibitors  of apoptosis such as  Bcl2, 
as well as activation of  the pro-mitotic NF-kappab 
[16,17]
system.  These various molecular changes drive 
cellular proliferation. Nonetheless, Cryptosporidium 
could have pro or anti apoptotic effects depending the 
[16,17,18]
stage of its life cycle.  At its trophozoite stage it 
inhibits apoptosis, while it promotes apoptosis at the 
[16]
sporozoite and merozoite stages.
Toxoplasma gondii
Toxoplasma gondii is a coccidian unicellular protozoan 
of the class Sporozoa and genus Toxoplasma. The first 
recorded relationship between this obligate 
[5]
intracellular parasite and neoplasia was in 1967.  A 
positive correlation between the prevalence of 
Toxoplasma  gondii and  brain cancer in adults has 
accounted for 17.8% of global cancer burden, while 
there would be 7.7% less cancer cases in the developed 
world if associated infections were treated or 
[6]
prevented.  Notably, it has been documented that 
[7]
cancers due to infections are progressively increasing.  
Infectious agents have been known to incite a chronic 
inflammatory response with generation of genotoxic 
free radicals, an altered internal milieu of cytokines 
stimulating rapid cell turnover and metaplastic 
[8]
change.  These create a biological setting predisposing 
to genetic damage and impaired DNA repair.  
However, microbial pathogens are now known to 
directly cause DNA mutations, cell cycle modulation, 
[9]
dysregulation of DNA and resistance to apoptosis.  A 
larger part of the available literature on infection 
associated cancers has revolved around the role of 
viruses and bacteria. Insomuch that it has been once 
stated that “the classic theory of carcinogenesis 
revolves around radiation, chemicals and viral 
[10]
infection”.   Helminths, on the other hand, are largely 
believed to largely cause self limiting infectious 
ailments, save in states of immunosuppression where 
the prognosis is worsened by an impaired immune 
response. Amidst parasites/helminths, only 
multicellular metazoans such as liver flukes and 
Schistosomes are presently recognized by  the 
International Agency for Research in Cancer [IARC] to 
[1]
have established roles in carcinogenesis.
The first link between parasites and cancers was first 
[11]
highlighted by Fibiger in 1926. He observed that mice 
infected with Spiroptera later developed gastric cancer. 
[11]
This was  later disproved by other researchers.  
However, this heightened the interest in the possible 
role of protozoa in cancers and has led to the 
unearthing of numerous new concepts about the 
impact of protozoa in the formation and progression of 
cancers. Recent research has led to an increase in the 
number of protozoan pathogens with suspected or 
confirmed roles as carcinogens.  In the same vein, 
molecular changes that underlie the neoplastic changes 
seen in a background of known parasitic carcinogens 
have been unravelled a step further. This article will 
look at new molecular pathways implicated in parasite 
induced  carcinogenesis, particularly with regards cell 
cycle regulation, apoptosis, and DNA repair, while 
exploring links between recently unassociated 
protozoans and cancers.  It equally seeks to strengthen 
the case for increased surveillance, prophylaxis and 
treatment of parasitic infection as part of cancer control 
and prevention.
METHOD OF REVIEW
To review relevant literature on the role of parasites in 
the formation of cancers, emphasizing largely 
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with T.vaginalis while infection with the organism was 
[5, 30]
observed in 4-5% of cervical cancer cases in China.   
Seropositivity for T.vaginalis was associated with a 
statistically significant elevation in the risk of 
[31,32]
metastatic cancer of the prostate.  African 
Americans who have the highest risk of carcinoma of 
the prostate, equally have the highest incidence of 
trichomoniasis, while the level of serum antibodies 
against a-actinin protein [derived from T.Vaginalis] 
correlates with an increased risk of having prostate 
[23, 31]
cancer.   
Upon adherence and entry into Prostatic Epithelial 
cells [PECs], this organism triggers proto-oncogenes 
such as [c-myc, PIM1 and HMGA1], which drive 
[5]
limitless cell proliferation.  T.vaginalis has also been 
demonstrated to alter the expression of junctional 
[5]
proteins such as E-cadherin, Occludin, and ZO-1.  A 
T.vaginalis protein, homologous to Human 
Macrophage Inhibitory Factor [MIF] has been 
[32]
identified in infected cells.  This protein, called TvMIF 
triggers pathways involved in cell proliferation and 
inflammation. TvMIF activates the anti-apoptotic Akt 
pathway via silencing of the pro-apoptotic BAD 
[32]
protein.  Its human homologue has been implicated 
in oncogenic transformation, as  over expression has 
been observed in various human cancers. Interestingly, 
MIF over expression interferes with p53 activity, thus 
[33]
promoting accumulation of oncogenic mutations.    
With regards cervical cancer, a study by Donders 
observed that T. Vaginalis infection correlated 
positively with both low risk and high risk HPV 
[34]
infection.  Infection with this protozoan was 
associated with a slightly higher rate of Atypical 
Squamous Cells of Undetermined Significance 
[ASCUS] when co-existing with High Risk HPV than 
[34]
when only the viral infection is present.  As only 1% of 
HSIL cases seen in this study harbored the protozoan, 




Theileria is a genus of parasitic protozoan that belongs 
to the phylum Apicomplexa and is closely related to  
Plasmodium. This intracellular protist is known to 
cause significant disease and death in both man and 
[23]
cattle, in Africa and Asia.  Theileria incites reversible 
transformation of leucocytes,  and induces 
[35]
lymphoproliferative diseases, which is often lethal. 
Theileria is equally known to induce the inhibition of 
apoptosis. It effects its anti apoptotic effect via the 
activation of NF-kb sequestering [and thus inhibiting] 
[23,35, 36]
the TP53 protein.  It equally enhances the secretion 
been demonstrated in 37 countries, while in France, an 
increased seroprevalence of Toxoplama gondii has 
been shown to be associated with increased brain 
[9, 19]
cancer mortality.   While elevated levels of anti 
Toxoplasma gondii antibodies have been seen in cases 
of meningioma and glioma, El-Gayar also documented 
increased risks for Hodgkin's and intraocular 
[5, 
lymphomas in patients infected with the protozoan. 
19,20]
 In Korea, the incidence of both primary and 
metastatic brain tumors were observed to be 
significantly higher in individuals infected with this 
[21]
intracellular protozoan.  In addition, the Chinese 
study by Yuan et al demonstrated an increase in the 
incidence of Nasopharyngeal  and rectal carcinomas in 
[22]
the presence of Toxoplasmosis.  
Toxoplasma persists in brain tissue within neurons, 
macrophages and pseudocysts, thus triggering a 
chronic inflammatory state. It is also known to alter 
[23]
host cell signaling, motility and morphology.  
Molecular studies have demonstrated that Toxoplasma 
turns host cells resistant to apoptosis by impairing 
activation of  pro-apoptotic molecules such as caspase-
8, Bax and Bak while promoting the actions of anti-
[24]
apoptotic agents Bcl2 and Bfl1.  It sequesters the 
inhibitor component of NFkB, thus unleashing its pro-
[23]
mitotic functions.   This protozoan has also been 
demonstrated to gain control of host  cells, and up 
regulates miR-1792 cluster which is associated with 
[25]
brain cancers.  This cluster of micro-RNAs is pivotal 
to the regulation of the cell-cycle, proliferation and 
[26]
apoptosis.  Its dysregulation has been equally 
strongly linked to haematopoietic and solid cancers, 
insomuch that it is equally referred to as “oncomir-
[26]
1”.  Cells infected with Toxoplasma have been shown 
to be resistant to Fas-dependent and Fas-independent 
[24]
pathways of Cytotoxic T cell induced apoptosis.  
Bradyzoites of this organism have been demonstrated 
to impede apoptosis following exposure to UV and 
gamma irradiation, toxins and deficiency of growth 
[27-29]
factors.  The growth effects of Toxoplasma have 
been demonstrated to vary, depending on its 
developmental stage. Latent slow growing bradyzoites 
induce gene dysregulation to a lesser extent than faster 
[23]
growing tachyzoites.  
Trichomonas vaginalis
This protozoan is a pear shaped flagellated organism of 
the class Mastigophora, and genus Trichomonas is 
known to cause vaginitis in females and urethritis in 
[12]
males.   It has recently been  linked to two 
malignancies of the reproductive tract, cervical cancer 
in females and prostate cancer in males. In the United 
states and Canada, the incidence of cervical cancer was 
said to be three times higher in persons with infection 
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[47-50]
the cervix.  Further insight into the oncogenic 
potential of this trematode has emerged, as a number of 
studies have uncovered key molecular events such as 
activation of the H-Ras oncogene and inactivation the 
tumour suppressors p53 and Retinoblastoma [Rb] 
genes have been observed in cases of Schistosomiasis 
[51,52, 53]
associated with cancer of the bladder.
Schistosoma mansoni and Schistosoma japonicum
Although Schistosoma haematobium appears to be the 
only member of this specie that has an established role 
in cancer formation. The documented link between 
infection by this trematode and squamous cell 
carcinoma of the bladder has affirmed its status as a 
carcinogen. Interestingly, new insights have merged on 
the relationship between other members of this specie 
and cancers. Fifty one [51%] of cases of Hepatocellular 
Carcinoma [HCC] seen in Japan, had infection with 
[54]
Schistosoma japonicum.  A post mortem study 
involving 571 autopsies demonstrated an increased 
[54]
incidence of Schistosomiasis among cases of HCC.  
This malignancy appears early and in larger numbers 
[55]
in experimental S.jap infection.   In China, a case 
control analysis showed a strong association between 
Schistosoma japonicum infection and rectal carcinoma 
[55]
but no association with Colonic Carcinoma.
There have been isolated case reports linking 
Schistosoma mansoni and cancer of the prostate, 
whereas the organism also has a direct association with 
HCC. A study of 1577 spleen biopsies from patients 
with Schistosoma mansoni infection showed the 
[6]
presence of follicular lymphomas.  Patients with 
Schistosoma japonicum have higher rates of infection 
with Hepatitis B and Hepatitis C viruses. This can be 
partly explained by the increased use of parenteral 
medication and blood transfusions. In addition cell 
mediated immunity in active Schistosoma japonicum, 
[55]
thus promoting chronic infection by these viruses.  
Mostafa in Egypt, observed a direct relationship 
between chronic Schistosomiasis and Hepatocellular 
carcinoma, that wasn't restricted to its potentiating of 
[56]
viral hepatitis.
Altered expression of the tumour suppressor protein 
p53 in cases of colorectal cancer associated with 
schistosomal colitis indicates that it is an early/inciting 
[54,57]
event in the development of colorectal cancer.  
Schistosoma mansoni impairs the functions of 
cytochrome enzymes, cytoP450, cyto b-5 and NADPH 
cyto reductase activity, all leading to enhanced effects 
[6]
of aflatoxin on the liver.   
Opistorchis viverrini
Opistorchis viverrini, known to be a causative agent of 
bile duct cancer, has been demonstrated to secrete a 
of Granulocyte Monocyte-Colony Stimulating Factor 
[GM-CSF] which stimulates host cell proliferation. This 
cytokine [GM-CSF] induces the oncogene c-Myc, while 
constitutive activation of the oncogene C-jun kinase 
[37-39]
has also been documented.  Theileria spp has also 
been known to alter host cell cytoskeleton, increasing 




Blastocystis Hominis is a protozoan intestinal parasite 
belonging to the Blastocystis genus of Stramenopiles-
vast array of organisms including brown algae, water 
molds, and diatoms. It has a widespread geographic 
distribution and is found in countries of all income 
[40]
levels across the world.  This genus of single celled 
parasites is the most common protozoan infection in 
the United States. Infection rates vary from about 23% 
[41]
in the States to up to 100% in less developed nations.  
It's a very common cause of GI symptoms in cancer 
[42]
patients and the immunosuppressed.  A study 
carried out in Malaysia observed that 21.08% of 
patients with colorectal cancer were positive for 
[43]
Blastocystis infection.
Blastocystis sp has been demonstrated to facilitate the 
[43]
growth of colorectal cancer cells in-vitro.   This pro-
mitotic impact is mediated through two modalities. 
Firstly, cells of a colorectal carcinoma express higher 
levels of Interleukins 6 and 8 in the presence of 
Blastocystis. Signalling induced by these cytokines lead 
[42]
to increased cell turnover and impaired apoptosis.  In 
the same vein, dysregulation of the p 53 gene and an 
impaired immune response [due to altered secretion 
and action of Interferon gamma], contribute to growth 
[43]
of colonic cancer cells.
Plasmodium falciparum
Alongside Epstein Barr Virus infection, holoendemic 
malaria, caused by Plasmodium falciparum infection, 
[44]
has strong but unproven links to Burkitt lymphoma.   
Recently, Cysteine rich interdomain region 1a[CIDR-
1a], a microbial protein found on the surface of infected 
erythrocytes has been demonstrated to interact with B 
lymphocytes. This induces B lymphocyte proliferation, 
[45,46]
cytomegaly, and secretion of immunoglobulins. . 
This molecule has also been documented to protect B 
[45]
cells from apoptosis.  
NEW ROLES FOR ESTABLISHED PARASITIC 
CARCINOGENS
Schistosoma haematobium
Its long standing links to the causation of Squamous 
cell carcinoma of the bladder notwithstanding, 
Schistosoma haematobium has recently been linked to 
cancers of the prostate and squamous cell carcinoma of 
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Neurocysticercosis is the most  common parasitic 
[61]
infection of the central nervous system.  Caused by 
the tapeworm Taenia solium, it has been associated 
with gliomas of the central nervous system. The 
association between neurocysticercosis and gliomas 
[61, 62]
has been mostly reported in endemic regions.   A 
number of studies have demonstrated direct and 
indirect links between neurocyctcercosis and gliomas. 
It has been hypothesized that the chronic inflammation 
induced by the parasite may cause cellular 
proliferation and increases the risk of mutations. 
Conversely, some authorities have suggested that the 
neurocysticercosis was a consequence rather than a 
[61, 62]
cause of the formation of gliomas.  This disproved 
hypothesis was hinged on the suggestion that the 
immunosuppressed state induced by the cancer would 
[63,64]
promote the growth of cysticerci.  
CONCLUSION
With increased sensitivity and specificity of laboratory 
techniques and the consequent proficiency in 
demonstrating alteration of cell proliferation and 
apoptosis, the role of protozoa in cancer formation has 
been established. Inasmuch as this could partly explain 
the sustained increase in the number of malignancies 
seen in Sub Saharan Africa and other tropical regions of 
the world, it equally signals the need to screen for 
cancer associated parasites and treat/give 
[7]
prophylaxis.
The multi-step nature of microbial/protozoan 
carcinogenesis provides ample opportunities for 
[ 6 5 ]
interventions to mitigate/prevent cancer.  
Antimicrobial treatments have a favourable effect on 
prognosis in cancers and Oncologists will benefit from 
an understanding of the mechanisms of infected 
related carcinogenesis to develop novel effective 
cancer control strategies. In the same vein, a much more 
robust investment of resources should be made in the 
screening and treatment of chronic parasitic infection, 
as well as a heightened index of suspicion of incipient 
neoplastic transformation in a background of such 
infections.  
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